Minimal Residual Disease (MRD) By 8-Color Flow Cytometry (Flow-MRD) and IGH Clonospecific Quantitative PCR (ASO RQPCR) Reached Similar Performances for Evaluation of CLL Treatment in a Phase II Clinical Trial: Cross Validation of the Methods

被引：0

作者：

Letestu, Remi ^{[1
]}

Cartron, Guillaume ^{[2
]}

Lepretre, Stephane ^{[3
]}

Le Garff-Tavernier, Magali ^{[4
]}

Solly, Francoise ^{[5
]}

Campos, Lydia ^{[5
]}

Ticchioni, Michel ^{[6
]}

Quiney, Claire ^{[4
]}

Dahmani, Abdelmalek ^{[1
]}

Boubaya, Marouane ^{[1
]}

Levy, Vincent ^{[1
]}

Cymbalista, Florence ^{[7
]}

Delfau-Larue, Marie-Helene ^{[8
]}

机构：

[1] Hop Avicenne, F-93009 Bobigny, France

[2] CHU St Eloi, Montpellier, France

[3] CLCC H Becquerel, Rouen, France

[4] AP HP, Paris, France

[5] St Etienne Univ Hosp, St Etienne, France

[6] Hop Archet, Nice, France

[7] Hop Avicenne, Paris, France

[8] Hop Henri Mondor, F-94010 Creteil, France

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3